Jul 1, 2026 04:01PM
Jun 11, 2026 07:03AM
Jun 11, 2026 07:03AM
Jun 11, 2026 07:02AM
Jun 11, 2026 07:00AM
Jun 4, 2026 04:01PM
Jun 4, 2026 07:00AM Syndax raises $250 million through convertible notes offering
Jun 4, 2026 07:00AM
Jun 2, 2026 04:01PM
Jun 2, 2026 04:01PM
Jun 1, 2026 07:00AM
Jun 1, 2026 07:00AM
May 21, 2026 05:01PM
May 21, 2026 05:01PM Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data
May 20, 2026 07:00AM
May 12, 2026 10:31AM
May 6, 2026 04:01PM
Apr 30, 2026 04:01PM
Apr 24, 2026 07:00AM
Apr 3, 2026 04:01PM
Mar 4, 2026 04:01PM Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Feb 26, 2026 04:01PM
Feb 23, 2026 07:00AM
Feb 19, 2026 07:00AM
Feb 5, 2026 07:00AM
Feb 4, 2026 04:01PM
Jan 12, 2026 07:08AM
Jan 12, 2026 07:00AM Syndax Reports Preliminary 2025 Financial Highlights and Provides Business Updates at the 44th Annual J.P. Morgan Healthcare Conference
Jan 7, 2026 07:00AM
Jan 5, 2026 07:00AM
Dec 12, 2025 07:00AM
Dec 9, 2025 04:34AM
Dec 8, 2025 06:50AM
Dec 8, 2025 06:50AM
Dec 3, 2025 04:01PM Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Dec 1, 2025 07:00AM
Nov 5, 2025 04:01PM
Nov 3, 2025 04:01PM
Nov 3, 2025 09:09AM
Nov 3, 2025 09:08AM
Nov 3, 2025 09:08AM
Oct 30, 2025 07:00AM Syndax Announces Participation in November Investor Conferences
Oct 27, 2025 07:48AM
Oct 27, 2025 07:00AM
Oct 24, 2025 01:59PM
Oct 24, 2025 01:58PM
Oct 24, 2025 01:08PM
Oct 3, 2025 04:01PM
Sep 19, 2025 07:00AM NCCN adds Syndax's Revuforj to leukemia treatment guidelines
Sep 19, 2025 07:00AM

325,451 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All